RETRACTION: Inhibition of Notch1 reverses EMT and chemoresistance to cisplatin via direct down-regulation of MCAM in triple-negative breast cancer cells (Retraction of Vol 147, Pg 490, 2020)

被引：0
|
作者：
Zeng, De
Liang, Yuan-Ke
Xiao, Ying-Sheng
Wei, Xiao-Long
Lin, Hao-Yu
Wu, Yang
Bai, Jing-Wen
Chen, Min
Zhang, Guo-Jun
机构：
来源：
INTERNATIONAL JOURNAL OF CANCER | 2024年 / 154卷 / 03期
关键词：
D O I：
10.1002/ijc.34792
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：E4 / E4
页数：1
相关论文
共 50 条
  • [41] Baicalein sensitizes triple negative breast cancer MDA-MB-231 cells to doxorubicin via autophagy-mediated down-regulation of CDK1
    Hua, Fang
    Xiao, Yi-Yi
    Qu, Xin-Hui
    Li, Shan-Shan
    Zhang, Kun
    Zhou, Chao
    He, Jian-Le
    Zhu, Ye
    Wan, Yu-Ying
    Jiang, Li-Ping
    Tou, Fang-Fang
    Han, Xiao-Jian
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2023, 478 (07) : 1519 - 1531
  • [42] RETRACTION: MiR-140-5p inhibits cell proliferation and metastasis by regulating MUC1 via BCL2A1/MAPK pathway in triple negative breast cancer (Retraction of Vol 18, Pg 2641, 2019)
    Yu, Bofan
    You, Wei
    Chen, Guang
    Yu, Yang
    Yang, Qinheng
    CELL CYCLE, 2022, 21 (23) : 2556 - 2556
  • [43] RETRACTION: NCTD elicits proapoptotic and antiglycolytic effects on colorectal cancer cells via modulation of Fam46c expression and inhibition of ERK1/2 signaling (Retraction of Vol 22, Pg 774, 2020)
    Zhang, Shiqiang
    Yang, Yun
    Hua, Yunwei
    Hu, Chen
    Zhong, Yi
    MOLECULAR MEDICINE REPORTS, 2023, 28 (04)
  • [44] Suppressive effects of plumbagin on invasion and migration of breast cancer cells via the inhibition of STAT3 signaling and down-regulation of inflammatory cytokine expressions (vol 1, pg 362, 2013)
    Yan, Wei
    Tu, Bing
    Liu, Yun-yun
    Wang, Ting-yu
    Qiao, Han
    Zhai, Zan-jing
    Li, Hao-wei
    Tang, Ting-ting
    BONE RESEARCH, 2019, 7 (1)
  • [45] RETRACTION: Down-regulation of long noncoding RNA PVT1 inhibits esophageal carcinoma cell migration and invasion and promotes cell apoptosis via microRNA-145-mediated inhibition of FSCN1 (vol13, pg 2554, 2019) (Retraction of Vol 13, Pg 2554, 2019)
    Shen, S-N
    Li, K.
    Liu, Y.
    Yang, C-L
    He, C-Y
    Wang, H-R
    MOLECULAR ONCOLOGY, 2022, 16 (22) : 4061 - 4061
  • [46] RETRACTION: Comprehensive analysis of FKBP4/NR3C1/TMEM173 signaling pathway in triple-negative breast cancer cell and dendritic cell among tumor microenvironment (Retraction of Vol 24, Pg 371, 2022)
    Xiong, Hanchu
    Chen, Zihan
    Lin, Baihua
    Chen, Weijun
    Li, Qiang
    Li, Yucheng
    Fang, Min
    Wang, Ying
    Zhang, Haibo
    Lu, Yanwei
    Bi, Aihong
    Wu, Shuqiang
    Jia, Yongshi
    Wang, Xiao
    MOLECULAR THERAPY-ONCOLYTICS, 2022, 25 : 263 - 263
  • [47] RETRACTION: LncRNA DLX6-AS1 contributes to epithelial-mesenchymal transition and cisplatin resistance in triple-negative breast cancer via modulating miR-199b-5p/paxillin axis
    Du, C.
    Wang, Y.
    Zhang, Y.
    Zhang, J.
    Zhang, L.
    Li, J.
    CELL TRANSPLANTATION, 2024, 33
  • [48] RETRACTION: LncRNA MALAT1 Regulates the Progression and Cisplatin Resistance of Ovarian Cancer Cells via Modulating miR-1271-5p/E2F5 Axis (Retraction of Vol 12, Pg 9999, 2020)
    Wang, Y.
    Wang, X.
    Han, L.
    Hu, D.
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 3457 - 3457
  • [49] RETRACTION: Down-regulation of Androgen Receptor by 3,3′-Diindolylmethane Contributes to Inhibition of Cell Proliferation and Induction of Apoptosis in Both Hormone-Sensitive LNCaP and Insensitive C4-2B Prostate Cancer Cells (Retraction of Vol 66, Pg 10064, 2006)
    Bhuiyan, M. M. R.
    Li, Y.
    Banerjee, S.
    Wang, Z.
    Sarkar, F. H.
    Ahmed, F.
    Ali, S.
    CANCER RESEARCH, 2018, 78 (18) : 5473 - 5473
  • [50] RETRACTED: Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells (Retracted article. See vol. 17, pg. 2268, 2018)
    Wang, ZW
    Zhang, YX
    Li, YW
    Banerjee, S
    Liao, J
    Sarkar, FH
    MOLECULAR CANCER THERAPEUTICS, 2006, 5 (03) : 483 - 493
12345